Latest News


Research to look at the link between osteoarthritis and heart disease.

Generous funding from the Raymond E Purves Foundation will support innovative research to identify how osteoarthritis causes cardiovascular disease. $100,000 will go towards Dr Cindy Shu to continue her valuable project to better define the link between osteoarthritis and heart disease, and inform improved treatment. Nearly 2.5 million Australians currently suffer from osteoarthritis, with the disa.....
Read more

Category: Funding support

Common, easily accessible medication could reduce severe COVID-19 symptoms.

A group of blood pressure medications may hold the key to better outcomes for those with COVID-19, marking a significant breakthrough in the treatment of the virus. An exciting new study, involving researchers from across Australia and India, will investigate whether existing blood pressure medications can reduce the risk of severe disease as well as the duration of severe symptoms. Researchers fro.....
Read more

Category: New Treatment

New research challenges long-held views about high heels and joint pain .

New research has produced a surprising result, indicating high heel shoes may not be a problem for those with hip osteoarthritis. The condition is a very common joint disorder, contributing to tremendous pain for many older people and significant disability. Researchers from the Kolling Institute and the University of Sydney adopted an innovative approach, and evaluated the link between wearing sho.....
Read more

Category: Research Excellence

Congratulations Professor Rob Baxter.

Former Kolling Institute director Professor Rob Baxter received an Order of Australia medal in the Queen’s Birthday honour roll for his significant service to medical research, endocrinology and tertiary education. Professor Baxter has more than 20 years experience in breast cancer research, with expertise in cell biology, endocrinology and metabolic regulation. He has been a Professor in the Sydne.....
Read more

Category: Awards

New investment in innovative approach to osteoarthritis treatment.

Key research into the treatment of osteoarthritis is set to be strengthened with the Kolling’s Professor David Hunter receiving a large NHMRC investigator grant. The highly competitive grant was awarded to the Florance and Cope Chair of Rheumatology for a five-year project to transform treatment options and delivery of care for osteoarthritis. Professor Hunter welcomed the grant, saying osteoarthri.....
Read more

Category: Funding support

Research may lead to early warning test for COVID-19.

For many people with COVID-19, the first sign they had the virus was a loss in their sense of smell. Now a team from the Kolling Institute and Royal North Shore Hospital will investigate the correlation between the virus and early symptoms. Study lead Associate Professor Rory Clifton-Bligh said a loss of smell has emerged as a common symptom of COVID-19 infection, but the current data is relying on.....
Read more

Category: Research Excellence

Co-ordinated COVID-19 Research Response.

Kolling Institute researchers are a key part of a new Northern Sydney Local Health District COVID-19 Clinical Research Group. All major specialist disciplines are represented in the group, taking advantage of the breadth of knowledge across the health campus. Kolling researcher Associate Professor Clifton-Bligh said we formed the group because we saw a clear need to co-ordinate our clinical resear.....
Read more

Category: Research Excellence

Important national COVID-19 study.

For many people with heart disease there’s an increased level of anxiety around the implications of COVID-19, but it’s hoped a new study led by Royal North Shore Hospital will guide future treatment and improve health outcomes. Head of cardiology Professor Ravinay Bhindi has launched the AUS-COVID study, which will involve more than 800 patients in over 20 hospitals across Australia. The Kolling I.....
Read more

Category: Research Excellence

Multiple medications cause frailty, but this can be reversed .

A world-first study by a team from the Kolling Institute may inform the future use of multiple medications by older people, minimising adverse impacts including frailty. The longitudinal research is the first preclinical study to demonstrate that multiple medications can impair function in old age, and that stopping some can reduce harm. Research lead, Professor Sarah Hilmer said until now there’s.....
Read more

Category: Research Excellence

Celebrating 100 years of research excellence.

2020 is an important year for the Kolling Institute as it marks the 100 year anniversary of the research organisation. As the longest-running medical research institute in New South Wales, the Kolling has a very rich history. Originally named the Institute of Pathological Research of NSW, the organisation was established in a cottage within the grounds of Royal North Shore Hospital in 1920. Bioche.....
Read more

Category: Research Excellence